News‎ > ‎

Lilly to Acquire Avid Radiopharmaceuticals

posted Nov 8, 2010, 8:10 AM by 林昆儒   [ updated Nov 8, 2010, 8:15 AM ]
Indianapolis, IN and Philadelphia, PA -Eli Lilly and Company (NYSE: LLY) today announced that it has signed a definitive merger agreement to acquire Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intended for the detection and monitoring of chronic human diseases.